Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Estrella Immunopharma, Inc. - Common Stock
(NQ:
ESLA
)
1.683
+0.073 (+4.52%)
Streaming Delayed Price
Updated: 10:53 AM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
30,493
Open
1.520
Bid (Size)
1.610 (1)
Ask (Size)
1.690 (1)
Prev. Close
1.610
Today's Range
1.520 - 1.724
52wk Range
0.6300 - 1.800
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 14, 2025
Via
Benzinga
Estrella Immunopharma Regains Compliance with Nasdaq Listing Requirements
October 06, 2025
From
Estrella Immunopharma, Inc.
Via
Business Wire
Performance
YTD
+50.2%
+50.2%
1 Month
+50.2%
+50.2%
3 Month
+105.2%
+105.2%
6 Month
+112.0%
+112.0%
1 Year
+95.7%
+95.7%
More News
Read More
Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
June 05, 2025
From
Estrella Immunopharma, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 03, 2025
Via
Benzinga
Estrella Immunopharma Announces Approximately $3.35 Million Private Placement Equity Financing
June 03, 2025
From
Estrella Immunopharma, Inc.
Via
Business Wire
Estrella Immunopharma Initiates Second Cohort and Doses First Patient in STARLIGHT-1 Trial of EB103 in Advanced B-Cell Non-Hodgkin’s Lymphomas
May 29, 2025
From
Estrella Immunopharma, Inc.
Via
Business Wire
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Buy Rating With a Price Target of $14.00 From CB Capital Partners
March 05, 2025
From
Estrella Immunopharma, Inc.
Via
Business Wire
Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week
February 23, 2025
Via
Stocktwits
Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort
February 21, 2025
From
Estrella Immunopharma
Via
Business Wire
Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital
February 19, 2025
From
Estrella Immunopharma, Inc.
Via
Business Wire
This aTyr Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
February 18, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 27, 2024
Via
Benzinga
Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells
September 27, 2024
From
Estrella Immunopharma, Inc.
Via
Business Wire
Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member
August 14, 2024
From
Estrella Immunopharma, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
August 02, 2024
Via
InvestorPlace
ESLA Stock Earnings: Estrella Immunopharma Reported Results for Q3 2024
May 20, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 08, 2024
Via
Benzinga
Next Big Thing: 3 Biotech Stocks to Watch for Groundbreaking Advances
January 18, 2024
Via
InvestorPlace
Topics
Economy
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 17, 2024
Via
Benzinga
Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
January 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 16, 2024
Via
Benzinga
Frequently Asked Questions
Is Estrella Immunopharma, Inc. - Common Stock publicly traded?
Yes, Estrella Immunopharma, Inc. - Common Stock is publicly traded.
What exchange does Estrella Immunopharma, Inc. - Common Stock trade on?
Estrella Immunopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Estrella Immunopharma, Inc. - Common Stock?
The ticker symbol for Estrella Immunopharma, Inc. - Common Stock is ESLA on the Nasdaq Stock Market
What is the current price of Estrella Immunopharma, Inc. - Common Stock?
The current price of Estrella Immunopharma, Inc. - Common Stock is 1.683
When was Estrella Immunopharma, Inc. - Common Stock last traded?
The last trade of Estrella Immunopharma, Inc. - Common Stock was at 10/17/25 10:53 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.